Correlation Between Pluri and Phio Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pluri and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pluri and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pluri Inc and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on Pluri and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pluri with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pluri and Phio Pharmaceuticals.

Diversification Opportunities for Pluri and Phio Pharmaceuticals

0.13

Correlation Coefficient

Pluri  Phio Pharmaceuticals

Average diversification

The 3 months correlation between Pluri and Phio is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and Pluri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pluri Inc are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of Pluri i.e., Pluri and Phio Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pluri and Phio Pharmaceuticals

Given the investment horizon of 90 days Pluri is expected to generate 4.58 times less return on investment than Phio Pharmaceuticals. But when comparing it to its historical volatility, Pluri Inc is 1.36 times less risky than Phio Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  258.00  in Phio Pharmaceuticals Corp on August 15, 2024 and sell it today you would lose (2.00) from holding Phio Pharmaceuticals Corp or give up 0.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pluri Inc  vs.  Phio Pharmaceuticals Corp

Pluri Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pluri Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Phio Pharmaceuticals Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Pluri and Phio Pharmaceuticals

The main advantage of trading using opposite Pluri and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pluri position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.

The idea behind Pluri Inc and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.